e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Biomarkers of asthma and COPD: recent advances
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating microparticles in COPD exacerbations
J. Lascano, N. Kaipust, J. Lanfranco, M. Cearras, F. Caceres, C. Bidot, M. Gonzalez, W. Jy, Y. Ahn, M. Salathe, M. Campos (Miami, United States Of America)
Source:
Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Session:
Biomarkers of asthma and COPD: recent advances
Session type:
Oral Presentation
Number:
3835
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lascano, N. Kaipust, J. Lanfranco, M. Cearras, F. Caceres, C. Bidot, M. Gonzalez, W. Jy, Y. Ahn, M. Salathe, M. Campos (Miami, United States Of America). Circulating microparticles in COPD exacerbations. Eur Respir J 2010; 36: Suppl. 54, 3835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Time course of serum interleukin-6 during COPD exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Variability in eosinophil levels at start of severe exacerbations of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Time course of sputum and serum interleukin-6 during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005
Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005
Circulating fibrocytes in patients with chronic obstructive asthma
Source: Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases
Year: 2009
Leptin during COPD exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003
Corticosteroids and exacerbations of COPD
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Procalcitonin use in acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
IL-18 in infectious exacerbations of COPD
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept